Podcast available at https://www.patreon.com/posts/20012144
Yet another study has confirmed that legal access to marijuana leads to fewer problems with opiates. Researchers from the University of California San Diego and Weill Cornell Medical College concluded that “statewide medical cannabis legalization implemented in 1993 – 2014 in the US was associated with close to 30% reductions in Schedule III opioids received by Medicaid enrollees. The study, published in the journal Addiction, also found that medical cannabis legalization in states that have so far adopted it saves the federal government $7.46 million in annual Medicaid spending. Add to that an additional $6.54 million in savings for states. While the research showed a clear reduction in prescriptions of Schedule III opioids, it did not find a correlation between allowance of medical marijuana and use of drugs classified under the more restrictive Schedule II of the Controlled Substances Act.